Pieter De Muynck

Global Head of Marketing
Janssen Pharmaceutical Companies of Johnson & Johnson

Pieter De Muynck is Global Marketing Leader for Janssen, a company of Johnson and Johnson where he’s responsible for the global commercial strategy of medicines for pulmonary hypertension, a rare disease. Pieter has more than 17 years of experience in the life sciences industry. He started his career with J&J where he held positions with growing responsibility at Janssen, Vision Care and J&J Consumer. He also held various leadership positions at a local, regional and global level at Roche Pharma. Pieter is excited about an ongoing customer centricity and digital transformation initiative within the organization. For the future, he sees great potential in editing genes in an entire organism, and the industry’s efforts to develop personalized treatments which help to prevent sickness. Pieter holds a Master degree in Business Economics and an MBA from the Vlerick Management School.

Check out the incredible speaker line-up to see who will be joining Pieter.

Download The Latest Agenda

Day Two, 24th September 2020

Thursday, September 24th, 2020

11:20 AM Panel & Interactive Polling: How can the European healthcare industry better innovate on sustainable solutions to deliver greater value to patients and HCPs and boost the bottom-line?

Join our expert panel of commercial leaders as they share how they are creating more sustainable products and services, and effectively communicating the real-world value of their offerings to all stakeholders along the chain.

· How can you deliver on your global corporate goals to meet stakeholder expectations whilst delivering value to HCPs and patients?

· How can you best demonstrate the real-world value of your products to payers, providers and patients to boost brand loyalty and increase quality of life for your customers?

· How can you better collaborate with payers to build a sustainable pricing model that provides your company with a competitive edge?

· How can you drive in-house innovation to develop new services that supplement drugs and therapies to provide added value to customers and create new revenue streams for your business?

12:00 PM Afternoon Tea & Interactive Roundtables: What are the next big disruptors set to transform the pharma market and how can you use them to stay ahead of the curve and better meet increasing customer expectations today?

1. Transforming your CX with voice chat and other digital tools - Tim E. Fischer, Global Head of Channel Evolution & Operations, Merck

2. Leveraging data insights to create appealing customer value propositions - Alessandro Milli, Global Head of Commercial Excellence, Zambon

3. Training and motivating a digitally enabled workforce

4. Optimising your content development and content re-use for higher engagement - Hans Gilhuys, Head of Commercial Excellence EMEA, Gilead

5. Mastering omni-channel marketing to drive engagement rates – Antonio Ibarra, Head of Omnichannel Marketing, Spain, Grünenthal Group

6. Driving collaboration and innovation to deliver greater value to patients – Pieter De Muynck, Global Head of Marketing, Janssen Pharmaceutical Companies of Johnson & Johnson

7. Empowering your sales team with digital tools – Louise Hope, Sales Development Manager, Commercial Operations, Orion Corporation

8. Leveraging social listening to inform your marketing messages - Kym Jacks-Bryant, Global Head of Digital Centre of Excellence, Norgine

9. Breaking down silos to encourage cross-functional collaboration